INVESTING IN HEALTH AND LIFE SCIENCES

The article explores the promising potential of the biotech and life sciences industry, emphasizing the surge in venture capital funding, transformative breakthroughs, and the rapid expansion of global markets. As of 2021, the global Life Science market is valued at USD 162,480 million, with projections indicating growth to USD 376,130 million by 2027 at a 15.02% CAGR.

THERMA BRIGHT’s: COMMITMENT TO INNOVATION AMIDST ADVERSITY

Medical technology company, Therma Bright (#OTCQB: $TBRIF) is dedicated to advancing groundbreaking medical solutions with Preva® ischemic stroke solution, in collaboration with Inretio. 🚀Over the last 6 months, Therma Bright ($TBRIF) has been making waves on the OTC market with increasing volumes. 📊 Get ready to join an exciting and financially enriching journey? 📈 Look no further!

Revolutionizing Respiratory Health: Therma Bright’s Innovative AI-Driven Cough Detection

Therma Bright secures exclusive global license for AI4LYF’s Digital Cough Technology (DCT), a cutting-edge AI-powered solution that swiftly detects respiratory diseases, including COVID-19, through a smartphone app. This partnership expands the scope of DCT to various respiratory conditions, while Therma Bright invests in advancing medical technology. Get ready for a revolutionary approach to respiratory disease screening.

SAFE HAVEN FOR INVESTORS

Understanding bear markets matters more than one might think. Investors who are monitoring market developments must focus on third-quarter earnings announcements in October.

Unleash the power of innovation with Therma Bright Inc. (OTCQB: TBRIF)

AI To Drive Tech Earnings   Therma Bright’s Venowave Device and the ARC Act: Advancing Vascular Health in the United States Therma Bright Inc. (OTCQB: TBRIF) is a renowned developer and partner in the field of cutting-edge proprietary diagnostic and medical device technologies. Their commitment to addressing crucial medical and healthcare challenges is evident through […]